Dr. Bowden garners Lifetime Research Award
Dr. Charles L. Bowden, professor and chairman of psychiatry at the Health Science Center, received the Gerald Klerman Lifetime Research Award at the annual meeting of the American Psychiatric Association earlier this year.
This is the highest award bestowed by the National Depressive and Manic Depressive Association. Dr. Bowden, who occupies the Nancy Ullman Karren Chair in Psychiatry at the Health Science Center, was recognized for his major contributions to improving the treatment of bipolar disorder. He led research on the major study that resulted in approval of Depakote for treatment of bipolar disorder.
His research, funded by the National Institute of Mental Health for more than 20 years, has led to new knowledge on chemical disturbances in bipolar disorder and depression, and has clarified the primary symptoms of bipolar disorder in ways that have improved early diagnosis.
Dr. Bowden heads one of the 16 centers nationally in the largest long-term study on the course and effectiveness of comprehensive treatment approaches for bipolar disorders. This National Institute of Mental Health-funded program, called the STEP-BD for "Systematic Treatment Enhancement Program for Bipolar Disorder," involves a UTHSC department of psychiatry team including Drs. Cherie Gonzales, Rolando Medina, Peter Thompson, Jodi Gonzalez, Linda Rhodes and Maria Ruiz-Sweeney, and Martha Dahl and Nancy Peters. The program, launched in February, will study 5,000 persons across the United States.
Dr. Bowden is a professor in the UTHSC department of pharmacology and is president of the 1,600-member Texas Society of Psychiatric Physicians. Dr Bowden is internationally sought as a consultant to governmental scientific agencies, research pharmaceutical companies and medical groups.